MarketCap
Facebook
X
TelegramFive Prime Therapeutics, Inc. P/CF 2011-2026 | FPRX
P/CF Jährlich Five Prime Therapeutics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -9.52 | -1.46 | -2.87 | -4.98 | -14.4 | 3.22 | 40.3 | -3.16 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 40.3 | -14.4 | 0.89 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M |  Germany |
 |
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M |  USA |
 |
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | USA |
 |
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | USA |
 |
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | USA |
 |
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | USA |
 |
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | USA |
 |
Applied Therapeutics
APLT
|
-9.8 | - | - | $ 8.42 M | USA |
 |
Aptorum Group Limited
APM
|
-3.64 | $ 0.9 | -0.02 % | $ 6.62 M | China |
 |
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | France |
 |
ACADIA Pharmaceuticals
ACAD
|
20.2 | $ 22.46 | 0.72 % | $ 3.72 B | USA |
 |
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M |  Israel |
 |
Brainstorm Cell Therapeutics
BCLI
|
-0.696 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | USA |
 |
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Cara Therapeutics
CARA
|
-0.588 | - | -3.03 % | $ 260 M | USA |
 |
CASI Pharmaceuticals
CASI
|
-40.6 | - | - | $ 35.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - |  Russia |
 |
Fennec Pharmaceuticals
FENC
|
-13.5 | $ 6.81 | -0.58 % | $ 195 M | USA |
 |
ChromaDex Corporation
CDXC
|
35.6 | - | -0.88 % | $ 598 M | USA |
 |
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M |  Canada |
 |
Galectin Therapeutics
GALT
|
-7.47 | $ 2.37 | -0.04 % | $ 151 M | USA |
 |
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | USA |
 |
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
-0.142 | - | 17.91 % | $ 11.1 M | USA |
 |
Greenwich LifeSciences
GLSI
|
-15.8 | $ 23.76 | -0.96 % | $ 309 M | USA |
 |
BioNTech SE
BNTX
|
70.7 | $ 101.26 | -0.78 % | $ 27.2 B | Germany |
 |
Checkpoint Therapeutics
CKPT
|
-5.15 | - | - | $ 169 M | USA |
 |
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | USA |
 |
Aquestive Therapeutics
AQST
|
-8.91 | $ 4.14 | 1.1 % | $ 443 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-612 | $ 23.67 | 1.07 % | $ 3.01 B | USA |
 |
Heron Therapeutics
HRTX
|
-7.19 | $ 1.19 | 0.01 % | $ 198 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-1.14 | $ 1.45 | 2.13 % | $ 386 M | Britain |
 |
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | Canada |
 |
AstraZeneca PLC
AZN
|
13.6 | - | - | $ 96.9 B | Britain |
 |
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M | USA |
 |
InflaRx N.V.
IFRX
|
-3.72 | $ 1.81 | 12.11 % | $ 152 M | Germany |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 2.98 | 2.05 % | $ 4.91 M | Israel |
 |
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Inventiva S.A.
IVA
|
-11.2 | $ 5.14 | 0.19 % | $ 138 M | France |
 |
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | USA |
 |
bluebird bio
BLUE
|
-0.285 | - | - | $ 546 M | USA |